>Doesn't fast track, in and of itself, usually produce a faster review process?<
No. Fast Track without priority review does not speed up the FDA review process, although it may enable an earlier NDA/BLA submission than would otherwise be the case.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”